What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?
H&R GmbH & Co. KGaA (ETR:2HRA), is not the largest company out there, but it received a lot of attention from a substantial price movement on the XTRA over the last few months, increasing to €8.38 at one point, and dropping to the lows of €6.40. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether H&R GmbH KGaA's current trading price of €6.40 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at H&R GmbH KGaA’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
View our latest analysis for H&R GmbH KGaA
Is H&R GmbH KGaA still cheap?
Great news for investors – H&R GmbH KGaA is still trading at a fairly cheap price according to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that H&R GmbH KGaA’s ratio of 4.51x is below its peer average of 10.88x, which indicates the stock is trading at a lower price compared to the Chemicals industry. What’s more interesting is that, H&R GmbH KGaA’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
Can we expect growth from H&R GmbH KGaA?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Though in the case of H&R GmbH KGaA, it is expected to deliver a highly negative earnings growth in the next few years, which doesn’t help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.
What this means for you:
Are you a shareholder? Although 2HRA is currently trading below the industry PE ratio, the negative profit outlook does bring on some uncertainty, which equates to higher risk. Consider whether you want to increase your portfolio exposure to 2HRA, or whether diversifying into another stock may be a better move for your total risk and return.
Are you a potential investor? If you’ve been keeping an eye on 2HRA for a while, but hesitant on making the leap, I recommend you dig deeper into the stock. Given its current price multiple, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.
If you'd like to know more about H&R GmbH KGaA as a business, it's important to be aware of any risks it's facing. For example, we've found that H&R GmbH KGaA has 2 warning signs (1 is a bit concerning!) that deserve your attention before going any further with your analysis.
If you are no longer interested in H&R GmbH KGaA, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Valuation is complex, but we're here to simplify it.
Discover if H&R GmbH KGaA might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:2HRA
H&R GmbH KGaA
Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts.
Undervalued with reasonable growth potential.